These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 9771955)

  • 21. Radioprotectants: pharmacology and clinical applications of amifostine.
    Dorr RT
    Semin Radiat Oncol; 1998 Oct; 8(4 Suppl 1):10-3. PubMed ID: 9794995
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Promotion of cystine uptake, increase of glutathione biosynthesis, and modulation of glutathione status by S-2-(3-aminopropylamino)ethyl phosphorothioic acid (WR-2721) in Chinese hamster cells.
    Issels RD; Nagele A
    Cancer Res; 1989 Apr; 49(8):2082-6. PubMed ID: 2539252
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cardioprotection of rat heart myocytes with amifostine (Ethyol) and its free thiol, WR-1065, in vitro.
    Dorr RT; Lagel K; McLean S
    Eur J Cancer; 1996; 32A Suppl 4():S21-5. PubMed ID: 8976818
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Determination of WR-1065 in human blood by high-performance liquid chromatography following fluorescent derivatization by a maleimide reagent ThioGlo3.
    Chen J; Lu Z; Lawrence TS; Smith DE
    J Chromatogr B Analyt Technol Biomed Life Sci; 2005 May; 819(1):161-7. PubMed ID: 15797534
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Measurement of WR-2721, WR-1065, and WR-33278 in plasma.
    Fahey RC; Newton GL
    Int J Radiat Oncol Biol Phys; 1985 Jun; 11(6):1193-7. PubMed ID: 2987166
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Thiol WR-1065 and disulphide WR-33278, two metabolites of the drug ethyol (WR-2721), protect DNA against fast neutron-induced strand breakage.
    Savoye C; Swenberg C; Hugot S; Sy D; Sabattier R; Charlier M; Spotheim-Maurizot M
    Int J Radiat Biol; 1997 Feb; 71(2):193-202. PubMed ID: 9120355
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Degradation of 2-(3-aminopropylamino)-ethanethiol (WR-1065) by Cu-dependent amine oxidases and influence on glutathione status of Chinese hamster ovary cells.
    Meier T; Issels RD
    Biochem Pharmacol; 1995 Aug; 50(4):489-96. PubMed ID: 7646554
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Protection of cultured mammalian cells by S-2-(3-aminopropylamino)ethylphosphorothioic acid(WR-2721).
    Antoku S
    Int J Radiat Oncol Biol Phys; 1983 Oct; 9(10):1481-5. PubMed ID: 6313559
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Enhancement of fotemustine (Muphoran) cytotoxicity by amifostine in malignant melanoma cell lines.
    Merlin JL; Marchal S; Ramacci C; Berlion M; Poullain MG
    Anticancer Drugs; 2002 Feb; 13(2):141-7. PubMed ID: 11901306
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preclinical studies on the radioprotective efficacy and pharmacokinetics of subcutaneously administered amifostine.
    Cassatt DR; Fazenbaker CA; Kifle G; Bachy CM
    Semin Oncol; 2002 Dec; 29(6 Suppl 19):2-8. PubMed ID: 12577236
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Thiol and disulfide metabolites of the radiation protector and potential chemopreventive agent WR-2721 are linked to both its anti-cytotoxic and anti-mutagenic mechanisms of action.
    Grdina DJ; Shigematsu N; Dale P; Newton GL; Aguilera JA; Fahey RC
    Carcinogenesis; 1995 Apr; 16(4):767-74. PubMed ID: 7728953
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of dose and schedule on the efficacy of ethyol: preclinical studies.
    Cassatt DR; Fazenbaker CA; Kifle G; Bachy CM
    Semin Oncol; 2003 Dec; 30(6 Suppl 18):31-9. PubMed ID: 14727238
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Alkaline phosphatase promotes radioprotection and accumulation of WR-1065 in V79-171 cells incubated in medium containing WR-2721.
    Calabro-Jones PM; Fahey RC; Smoluk GD; Ward JF
    Int J Radiat Biol Relat Stud Phys Chem Med; 1985 Jan; 47(1):23-7. PubMed ID: 2982751
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An improved HPLC assay for S-2-(3-aminopropylamino)ethyl phosphorothioate (WR-2721) in plasma.
    Swynnerton NF; McGovern EP; Niño JA; Mangold DJ
    Int J Radiat Oncol Biol Phys; 1984 Sep; 10(9):1521-4. PubMed ID: 6090354
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Variation in normal tissue responsiveness to WR-2721.
    Yuhas JM; Afzal SM; Afzal V
    Int J Radiat Oncol Biol Phys; 1984 Sep; 10(9):1537-9. PubMed ID: 6090357
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacokinetics of WR-1065 in mouse tissue following treatment with WR-2721.
    Utley JF; Seaver N; Newton GL; Fahey RC
    Int J Radiat Oncol Biol Phys; 1984 Sep; 10(9):1525-8. PubMed ID: 6090355
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Subcutaneous administration of amifostine (ethyol) is equivalent to intravenous administration in a rat mucositis model.
    Cassatt DR; Fazenbaker CA; Kifle G; Bachy CM
    Int J Radiat Oncol Biol Phys; 2003 Nov; 57(3):794-802. PubMed ID: 14529786
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Opposite effects of WR-2721 and WR-1065 on radiation-induced hypothermia: possible correlation with oxygen uptake.
    Kandasamy SB; Kumar KS; Hunt WA; Weiss JF
    Radiat Res; 1988 May; 114(2):240-7. PubMed ID: 2836882
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The radioprotective agent, amifostine, suppresses the reactivity of intralysosomal iron.
    Yu Z; Eaton JW; Persson HL
    Redox Rep; 2003; 8(6):347-55. PubMed ID: 14980067
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The preclinical basis for broad-spectrum selective cytoprotection of normal tissues from cytotoxic therapies by amifostine.
    Capizzi RL
    Semin Oncol; 1999 Apr; 26(2 Suppl 7):3-21. PubMed ID: 10348255
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.